Here's what investors may want to know about DatChat and DATS stock, as this company sees investor interest soar in recent weeks. More
Articles
ChargePoint’s Sales Growth Is on Track to Push the Stock Higher
With sales growth on track, CHPT stock is worth at least $29 based on ChargePoint's 2026 revenue estimates, or about 39% more than today. More
Will the Real Clover Health Stock Please Stand Up?
Clover Health trades near its 52-week low of $6.31, well off its 52-week high of $28.85 in June. Will the real CLOV stock please stand up? More
Silver Stocks: Why Are CDE, EXK, FSM, AG, SVM and PAAS Stocks Sliding Lower Today?
Silver stocks aren't doing well on Wednesday and it looks like fears about the current economy are playing a part in that. More
EDIT Stock Is Plunging 20%. Here’s the Gene-Editing News Dragging It Down.
Today, investors in Editas Medicine and EDIT stock are pricing in some clinical trial results that are being viewed negatively by the market. More
Blackberry Provides an Interesting Long-Term Opportunity After Q2 Earnings
A few years into a major restructuring, Blackberry is yet to show real progress in its results. Still, BB stock could be a long-term winner. More
